The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study
Open accessAbstract
BACKGROUND: Invasive pneumococcal disease remains an important health priority owing to increasing disease incidence caused by pneumococci expressing non-vaccine serotypes. We previously defined 621 Global Pneumococcal Sequence Clusters (GPSCs) by analysing 20 027 pneumococcal isolates collected worldwide and from previously published genomic data. In this study, we aimed to investigate the pneumococcal lineages behind the predominant serotypes, the mechanism of serotype replacement in disease, as well as the major pneumococcal lineages contributing to invasive pneumococcal disease in the post-vaccine era and their antibiotic resistant traits. METHODS: We whole-genome sequenced 3233 invasive pneumococcal disease isolates from laboratory-based surveillance programmes in Hong Kong (n=78), Israel (n=701), Malawi (n=226), South Africa (n=1351), The Gambia (n=203), and the USA (n=674). The genomes represented pneumococci from before and after pneumococcal conjugate vaccine (PCV) introductions and were from children younger than 3 years. We identified predominant serotypes by prevalence and their major contributing lineages in each country, and assessed any serotype replacement by comparing the incidence rate between the pre-PCV and PCV periods for Israel, South Africa, and the USA. We defined the status of a lineage as vaccine-type GPSC (≥50% 13-valent PCV [PCV13] serotypes) or non-vaccine-type GPSC (>50% non-PCV13 serotypes) on the basis of its initial serotype composition detected in the earliest vaccine period to measure their individual contribution toward serotype replacement in each country. Major pneumococcal lineages in the PCV period were identified by pooled incidence rate using a random effects model. FINDINGS: The five most prevalent serotypes in the PCV13 period varied between countries, with only serotypes 5, 12F, 15B/C, 19A, 33F, and 35B/D common to two or more countries. The five most prevalent serotypes in the PCV13 period varied between countries, with only serotypes 5, 12F, 15B/C, 19A, 33F, and 35B/D common to two or more countries. These serotypes were associated with more than one lineage, except for serotype 5 (GPSC8). Serotype replacement was mainly mediated by expansion of non-vaccine serotypes within vaccine-type GPSCs and, to a lesser extent, by increases in non-vaccine-type GPSCs. A globally spreading lineage, GPSC3, expressing invasive serotypes 8 in South Africa and 33F in the USA and Israel, was the most common lineage causing non-vaccine serotype invasive pneumococcal disease in the PCV13 period. We observed that same prevalent non-vaccine serotypes could be associated with distinctive lineages in different countries, which exhibited dissimilar antibiotic resistance profiles. In non-vaccine serotype isolates, we detected significant increases in the prevalence of resistance to penicillin (52 [21%] of 249 vs 169 [29%] of 575, p=0·0016) and erythromycin (three [1%] of 249 vs 65 [11%] of 575, p=0·0031) in the PCV13 period compared with the pre-PCV period. INTERPRETATION: Globally spreading lineages expressing invasive serotypes have an important role in serotype replacement, and emerging non-vaccine serotypes associated with different pneumococcal lineages in different countries might be explained by local antibiotic-selective pressures. Continued genomic surveillance of the dynamics of the pneumococcal population with increased geographical representation in the post-vaccine period will generate further knowledge for optimising future vaccine design. FUNDING: Bill & Melinda Gates Foundation, Wellcome Sanger Institute, and the US Centers for Disease Control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Conducting Meta-Analyses in R with the metafor Package
Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464
Wahl, B., O'Brien, K. L., Greenbaum, A., Majumder, A., Liu, L., Chu, Y., Lukšić, I., Nair, H., McAllister, D. A., Campbell, H., et al. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30247-x · Cited by 1,118
Moore, M. R., Link-Gelles, R., Schaffner, W., Lynfield, R., Lexau, C., Bennett, N. M., Petit, S., Zansky, S. M., Harrison, L. H., Reingold, A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71081-3 · Cited by 733
Self-citationPneumococcal Capsules and Their Types: Past, Present, and Future
Geno, K. A., Gilbert, G. L., Song, J. Y., Skovsted, I. C., Klugman, K. P., Jones, C., Konradsen, H. B., & Nahm, M. H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-15 · Cited by 732
Self-citationMiller, E., Andrews, N. J., Waight, P. A., Slack, M. P., & George, R. C. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70090-1 · Cited by 643
Brueggemann, A. B., Griffiths, D. T., Meats, E., Peto, T., Crook, D. W., & Spratt, B. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374624 · Cited by 619
Ladhani, S. N., Collins, S., Djennad, A., Sheppard, C. L., Borrow, R., Fry, N. K., Andrews, N. J., Miller, E., & Ramsay, M. E. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30052-5 · Cited by 559
Population Snapshot of Emergent Streptococcus pneumoniae Serotype 19A in the United States, 2005
Moore, M. R., Gertz, Jr., Woodbury, R. L., Barkocy‐Gallagher, G. A., Schaffner, W., Lexau, C., Gershman, K., Reingold, A., Farley, M., Harrison, L. H., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/528996 · Cited by 480
Self-citationFast and flexible bacterial genomic epidemiology with PopPUNK
Lees, J. A., Harris, S. R., Tonkin-Hill, G., Gladstone, R. A., Lo, S. W., Weiser, J. N., Corander, J., Bentley, S. D., & Croucher, N. J. (2019) · Genome Research · doi:10.1101/gr.241455.118 · Cited by 438
Self-citationBalsells, E., Guillot, L., Nair, H., & Kyaw, M. H. (2017) · PLOS ONE · doi:10.1371/journal.pone.0177113 · Cited by 393
Research works printed but not linked: 10
- Pilishvili, 2018, Use of data to drive pneumococcal conjugate vaccine policy, Lancet Infect Dis, 18, 366, 10.1016/S1473-3099(18)30054-9 · doi:10.1016/s1473-3099(18)30054-9
- Ladhani, 2018, Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study, Lancet Infect Dis, 18, 441, 10.1016/S1473-3099(18)30052-5 · DOI · Paper page
- Ben-Shimol, 2018, Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: insights from Israeli surveillance studies, Vaccine, 36, 5477, 10.1016/j.vaccine.2017.05.059 · DOI
- Schwarzer, 2007, meta: an R package for meta-analysis, R News, 7, 40
- Wiener-Well, 2009, Cefuroxime for empiric treatment of community-acquired pneumococcal pneumonia: is there a generation gap?, Chemotherapy, 55, 97, 10.1159/000192393 · doi:10.1159/000192393
- Hanage, 2011, Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination, Vaccine, 29, 8877, 10.1016/j.vaccine.2011.09.075 · doi:10.1016/j.vaccine.2011.09.075
- Weinberger, 2018, Invasive pneumococcal disease in children under 16 years of age: incomplete rebound in incidence after the maximum effect of PCV13 in 2012/13 in Germany, Vaccine, 3, 572, 10.1016/j.vaccine.2017.11.085 · DOI
- Zulz, 2013, Molecular characterization of Streptococcus pneumoniae serotype 12F isolates associated with rural community outbreaks in Alaska, J Clin Microbiol, 51, 1402, 10.1128/JCM.02880-12 · doi:10.1128/jcm.02880-12
- Foster, 2008, Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England, J Med Microbiol, 57, 480, 10.1099/jmm.0.47690-0 · doi:10.1099/jmm.0.47690-0
- Sharma, 2017, Atypical pneumonia, Clin Chest Med, 38, 45, 10.1016/j.ccm.2016.11.011 · doi:10.1016/j.ccm.2016.11.011
Cited by
Community-acquired bacterial meningitis.
van de Beek, D., Brouwer, M. C., Koedel, U., & Wall, E. C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00883-7 · Cited by 292
Gladstone, R. A., Lo, S. W., Lees, J. A., Croucher, N. J., van Tonder, A. J., Corander, J., Page, A. J., Marttinen, P., Bentley, L. J., Ochoa, T. J., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.021 · Cited by 257
Self-citationLi, S., Zhang, H., Xiao, J., Yuan, T., Shu, Z., Min, Y., Xu, W., Yin, Y., & Zhang, X. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00358 · Cited by 8
“Streptococcus pneumoniae and S. aureus are dominant colonization bacteria in the upper respiratory tract (Zemlickova et al., 2006; Thapa et al., 2017; Dunne et al., 2018; Lo et al., 2019).”
Background
Metadata
- Authors
- Lo, S. W., Gladstone, R. A., van Tonder, A. J., Lees, J. A., du Plessis, M., Benisty, R., Givon-Lavi, N., Hawkins, P. A., Cornick, J. E., Kwambana-Adams, B., Law, P. Y., Ho, P. L., Antonio, M., Everett, D. B., Dagan, R., von Gottberg, A., Klugman, K. P., McGee, L., Breiman, R. F., Bentley, S. D., Brooks, A. W., Corso, A., Davydov, A., Maguire, A., Pollard, A., Kiran, A., Skoczynska, A., Moiane, B., Beall, B., Sigauque, B., Aanensen, D., Lehmann, D., Faccone, D., Foster-Nyarko, E., Bojang, E., Egorova, E., Voropaeva, E., Sampane-Donkor, E., Sadowy, E., Bigogo, G., Mucavele, H., Belabbès, H., Diawara, I., Moïsi, J., Verani, J., Keenan, J., Nair Thulasee Bhai, J. N., Ndlangisa, K. M., Zerouali, K., Ravikumar, K. L., Titov, L., De Gouveia, L., Alaerts, M., Ip, M., de Cunto Brandileone, M. C., Hasanuzzaman, M., Paragi, M., Nurse-Lucas, M., Ali, M., Elmdaghri, N., Croucher, N., Wolter, N., Porat, N., Eser, Ö. K., Akpaka, P. E., Turner, P., Gagetti, P., Tientcheu, P.-E., Carter, P. E., Mostowy, R., Kandasamy, R., Ford, R., Henderson, R., Malaker, R., Shakoor, S., Grassi Almeida, S. C., Saha, S. K., Doiphode, S., Madhi, S. A., Devi Sekaran, S., Srifuengfung, S., Obaro, S., Clarke, S. C., Nzenze, S. A., Kastrin, T., Ochoa, T. J., Balaji, V., Hryniewicz, W., & Urban, Y.
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 19
- Issue
- 7
- Pages
- 759-769
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W2950614621
- Cited by
- 291
- References
- 40
- FWCI
- 18.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Bill and Melinda Gates Foundation (OPP1034556)
- Wellcome Trust (098051, 206194)
- Centers for Disease Control and Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. https://app.cochat.ai/papers/10.1016/s1473-3099(19)30297-x
- The paper
- Lo, S. W., Gladstone, R. A., van Tonder, A. J., Lees, J. A., du Plessis, M., Benisty, R., Givon-Lavi, N., Hawkins, P. A., Cornick, J. E., Kwambana-Adams, B., Law, P. Y., Ho, P. L., Antonio, M., Everett, D. B., Dagan, R., von Gottberg, A., Klugman, K. P., McGee, L., Breiman, R. F., . . . Urban, Y. (2019). Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(19)30297-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.